Lead Sponsor

Novartis

Age

12 - 75 years

Sex

ALL

Healthy Volunteers

No

•Males and females 12 - 75 years of age with a diagnosis of persistent asthma
•Daily treatment with a bronchodilator and daily dose of at least 100 µg beclomethasone dipropionate or equivalent
•FEV1 at Visit 1 at least 50% of the predicted normal value
•FEV1 reversibility at least 15%

•Use of tobacco products within 6 months prior to Visit 1 or a smoking history of more than 10 pack years
•Chronic Obstructive Pulmonary Disease (COPD)
•Seasonal allergy where asthma is likely to deteriorate during the period of the study
•Emergency room treatment for an acute asthma attack within the previous 6 weeks or hospitalized within the previous 6 months